|
| InsiderPie Expert Score
| P/E ratio
| Net margin
| ROA
| Net income per employee
|
| Boston Scientific Corporation
|
64
/ 100
| 63
| 13.5%
| 6.0%
| €40.31K
|
| Penumbra, Inc.
|
59
/ 100
| 67
| 11.5%
| 8.8%
| €28.00K
|
| Stryker Corporation
|
70
/ 100
| 52
| 12.3%
| 6.3%
| €46.96K
|
| Heska Corporation
|
50
/ 100
| -70
| -7.3%
| -3.1%
| -€19.63K
|
| Stratec SE
|
52
/ 100
| 108
| 6.2%
| 3.6%
| €10.96K
|
| Cytosorbents Corporation
|
50
/ 100
| -7.9
| -29.1%
| -20.3%
| -€55.81K
|
| Co-Diagnostics, Inc.
|
50
/ 100
| -0.25
| -3,586.0%
| -77.5%
| -€232.57K
|
| Apollo Endosurgery, Inc.
|
50
/ 100
| -15
| -51.8%
| -36.1%
| -€168.22K
|
| Insulet Corporation
|
70
/ 100
| 93
| 10.8%
| 6.8%
| €51.64K
|
| ShockWave Medical, Inc.
|
50
/ 100
| 77
| 20.7%
| 9.9%
| €95.00K
|
| BICO Group AB (publ)
|
56
/ 100
| -12
| -10.6%
| -4.5%
| -€27.23K
|
| Getinge AB (publ)
|
52
/ 100
| 34
| 4.2%
| 2.6%
| €11.28K
|
| Nevro Corp.
|
50
/ 100
| -2
| -27.8%
| -20.5%
| -€88.04K
|
| IRadimed Corporation
|
49
/ 100
| 37
| 26.6%
| 19.4%
| €110.12K
|
| Avanos Medical, Inc.
|
51
/ 100
| -1.2
| -66.9%
| -44.6%
| -€177.41K
|
| Globus Medical, Inc.
|
51
/ 100
| 22
| 13.6%
| 7.2%
| €57.40K
|
| Inogen, Inc.
|
50
/ 100
| -7.3
| -7.6%
| -8.3%
| -€29.00K
|
| EKF Diagnostics Holdings plc
|
51
/ 100
| 14
| 8.4%
| 10.5%
| €32.55K
|
| ThermoGenesis Holdings, Inc.
|
50
/ 100
| -0.00011
| -153.4%
| -146.2%
| -€503.07K
|
| Anika Therapeutics, Inc.
|
45
/ 100
| -2.5
| -66.0%
| -32.3%
| -€179.55K
|
| Integer Holdings Corporation
|
53
/ 100
| 31
| 7.6%
| 4.0%
| €10.58K
|
| Alphatec Holdings, Inc.
|
45
/ 100
| -9.8
| -24.3%
| -21.0%
| -€163.31K
|
| Cardiovascular Systems, Inc.
|
50
/ 100
| -22
| -15.8%
| -12.2%
| -€44.55K
|
| Accelerate Diagnostics, Inc.
|
50
/ 100
| -0.017
| -427.8%
| -175.3%
| -€398.94K
|
| Zimmer Biomet Holdings, Inc.
|
51
/ 100
| 22
| 10.5%
| 3.6%
| €41.31K
|
| Pulmonx Corporation
|
50
/ 100
| -1.8
| -62.9%
| -38.7%
| -€166.90K
|
| SI-BONE, Inc.
|
49
/ 100
| -30
| -15.0%
| -11.7%
| -€64.89K
|
| Episurf Medical AB (publ)
|
50
/ 100
| -0.86
| -498.5%
| -100.1%
| -€226.54K
|
| PAVmed Inc.
|
50
/ 100
| 0.14
| 1,039.0%
| 166.0%
| €1.59M
|
| Euroapi S.A.
|
46
/ 100
| -0.85
| -16.6%
| -21.5%
| -€100.50K
|
| aap Implantate AG
|
50
/ 100
| -5.7
| -32.9%
| -20.8%
| -€46.21K
|
| Carmat SA
|
50
/ 100
| -0.45
| -1,073.3%
| -248.3%
| -€650.28K
|
| CellaVision AB (publ)
|
50
/ 100
| 29
| 20.1%
| 14.4%
| €59.38K
|
| CONMED Corporation
|
50
/ 100
| 15
| 8.3%
| 4.7%
| €24.10K
|
| Abbott Laboratories
|
51
/ 100
| 17
| 32.4%
| 16.6%
| €104.59K
|
| Perspective Therapeutics, Inc.
|
50
/ 100
| -2.5
| -19,728.6%
| -36.6%
| -€702.37K
|
| Inspire Medical Systems, Inc.
|
56
/ 100
| 74
| 6.2%
| 6.6%
| €36.36K
|
| Nuwellis, Inc.
|
50
/ 100
| -0.028
| -176.4%
| -159.5%
| -€329.42K
|
| Cytek Biosciences, Inc.
|
53
/ 100
| -70
| -3.3%
| -1.3%
| -€8.23K
|
| Eckert & Ziegler Strahlen- und Medizintechnik AG
|
53
/ 100
| 39
| 12.2%
| 8.3%
| €33.77K
|
| Glaukos Corporation
|
49
/ 100
| -62
| -21.4%
| -9.4%
| -€79.54K
|
| Senseonics Holdings, Inc.
|
50
/ 100
| -5.4
| -255.2%
| -68.9%
| -€504.39K
|
| OrthoPediatrics Corp.
|
50
/ 100
| -13
| -18.9%
| -8.3%
| -€63.38K
|
| Abiomed, Inc.
|
50
/ 100
| 64
| 24.8%
| 15.7%
| €113.60K
|
| Boule Diagnostics AB (publ)
|
50
/ 100
| -1.4
| -48.0%
| -53.2%
| -€110.82K
|
| ZimVie Inc.
|
50
/ 100
| -13
| -4.4%
| -2.6%
| -€9.38K
|
| Tactile Systems Technology, Inc.
|
50
/ 100
| 16
| 5.1%
| 5.5%
| €12.43K
|
| Surmodics, Inc.
|
50
/ 100
| -23
| -14.6%
| -10.4%
| -€38.65K
|
| CYBERDYNE Inc.
|
50
/ 100
| -110
| -8.0%
| -0.7%
| -€8.58K
|
| Cerus Corporation
|
51
/ 100
| -14
| -9.8%
| -8.9%
| -€26.23K
|
| Edwards Lifesciences Corporation
|
54
/ 100
| 11
| 73.0%
| 30.7%
| €223.91K
|
| Geratherm Medical AG
|
50
/ 100
| -22
| -4.5%
| -2.5%
| -€4.64K
|
| Beyond Air, Inc.
|
50
/ 100
| -0.5
| -880.7%
| -149.8%
| -€335.72K
|
| Ambu A/S
|
50
/ 100
| 73
| 6.0%
| 4.9%
| €9.62K
|
| Smith & Nephew plc
|
52
/ 100
| 20
| 7.3%
| 6.0%
| €31.77K
|
| Circassia Group Plc
|
54
/ 100
| 0
| 16.8%
| 19.3%
| €136.45K
|
| Apyx Medical Corporation
|
49
/ 100
| -4.7
| -37.1%
| -29.7%
| -€66.91K
|
| Nemaura Medical Inc.
|
50
/ 100
| -0.00064
| 405.3%
| -121.8%
| -€149.19K
|
| Xtant Medical Holdings, Inc.
|
50
/ 100
| -19
| -3.6%
| -4.4%
| -€18.01K
|
| Semler Scientific, Inc.
|
49
/ 100
| 12
| 86.2%
| 7.1%
| €399.98K
|
| Senzime AB (publ)
|
50
/ 100
| -6.3
| -156.8%
| -29.0%
| -€209.62K
|
| Varex Imaging Corporation
|
50
/ 100
| -2.7
| -16.1%
| -12.3%
| -€49.14K
|
| iRhythm Technologies, Inc.
|
47
/ 100
| -53
| -14.1%
| -9.6%
| -€39.42K
|
| STRATA Skin Sciences, Inc.
|
50
/ 100
| -0.81
| -35.1%
| -37.6%
| -€92.86K
|
| Allied Healthcare Products, Inc.
|
50
/ 100
| 0
| -20.2%
| -27.7%
| -€31.85K
|
| EL.En. S.p.A.
|
50
/ 100
| 21
| 7.6%
| 0.0%
| €20.35K
|
| GN Store Nord A/S
|
51
/ 100
| 16
| 5.0%
| 3.0%
| €16.03K
|
| Xvivo Perfusion AB (publ)
|
50
/ 100
| 45
| 27.2%
| 9.0%
| €94.78K
|
| DexCom, Inc.
|
80
/ 100
| 59
| 13.3%
| 7.8%
| €47.79K
|
| Helius Medical Technologies, Inc.
|
50
/ 100
| -4.9
| -7,215.3%
| -269.7%
| -€864.53K
|
| Integra LifeSciences Holdings Corporation
|
50
/ 100
| -1.9
| -30.9%
| -49.9%
| -€97.14K
|
| Demant A/S
|
51
/ 100
| 14
| 9.3%
| 12.9%
| €28.13K
|
| electroCore, Inc.
|
50
/ 100
| -3.1
| -47.8%
| -91.0%
| -€154.83K
|
| Sintx Technologies, Inc.
|
49
/ 100
| -0.64
| -693.0%
| -136.4%
| -€534.97K
|
| Polarean Imaging plc
|
50
/ 100
| -1.3
| -425.6%
| -82.5%
| -€515.58K
|
| Tandem Diabetes Care, Inc.
|
52
/ 100
| -6.1
| -18.3%
| -23.5%
| -€66.13K
|
| Koninklijke Philips N.V.
|
51
/ 100
| 118
| 0.9%
| 0.6%
| €2.41K
|
| Align Technology, Inc.
|
53
/ 100
| 31
| 11.0%
| 7.0%
| €17.61K
|
| Drägerwerk AG & Co. KGaA
|
53
/ 100
| 9.8
| 3.0%
| 3.3%
| €6.47K
|
| Medacta Group SA
|
51
/ 100
| 24
| 10.9%
| 15.2%
| €63.06K
|
| Guerbet SA
|
50
/ 100
| 6.5
| 2.4%
| 3.9%
| €14.38K
|
| Venus Concept Inc.
|
50
/ 100
| -0.098
| -68.8%
| -65.5%
| -€120.74K
|
| Ion Beam Applications SA
|
50
/ 100
| 1.9K
| 0.0%
| 0.0%
| €89.71
|
| NuVasive, Inc.
|
50
/ 100
| 73
| 2.3%
| 1.4%
| €8.09K
|
| Sonova Holding AG
|
52
/ 100
| 12
| 15.2%
| 19.3%
| €65.85K
|
| Novacyt S.A.
|
50
/ 100
| -0.77
| -266.3%
| -29.2%
| -€191.82K
|
| InspireMD, Inc.
|
50
/ 100
| -1.7
| -585.6%
| -124.1%
| -€415.25K
|
| Asensus Surgical, Inc.
|
50
/ 100
| -1.1
| -850.8%
| -217.6%
| -€345.30K
|
| Axonics, Inc.
|
50
/ 100
| -641
| -1.3%
| -0.7%
| -€6.06K
|
| Artivion, Inc.
|
46
/ 100
| -34
| -5.5%
| -2.7%
| -€15.21K
|
| NeuroMetrix, Inc.
|
50
/ 100
| -1.2
| -257.4%
| -50.9%
| -€512.17K
|
| Myomo, Inc.
|
50
/ 100
| -8.7
| -22.9%
| -24.1%
| -€43.22K
|
| MaxCyte, Inc.
|
51
/ 100
| -5.2
| -125.2%
| -20.4%
| -€334.99K
|
| Deltex Medical Group plc
|
50
/ 100
| -0.29
| -55.5%
| -42.0%
| -€110.54K
|
| Bio-Rad Laboratories, Inc.
|
50
/ 100
| 27
| 10.0%
| 2.5%
| €28.27K
|
| Ikonisys S.A.
|
50
/ 100
| -4.2
| -440.8%
| -18.5%
| -€509.48K
|
| Medartis Holding AG
|
46
/ 100
| 235
| 0.9%
| 0.9%
| €5.44K
|
| Siemens Healthineers AG
|
55
/ 100
| 48
| 9.3%
| 4.9%
| €30.17K
|
| SeaSpine Holdings Corporation
|
50
/ 100
| 0
| -28.2%
| -17.3%
| -€105.74K
|
